Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation

Published:2022-09-22 Issue:1 Volume:108 Page:278-282
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Chiusolo Patrizia,Orlando Nicoletta,Giammarco Sabrina,Rossi Monica,Metafuni Elisabetta,Leotta Salvatore,Milone Giuseppe,Valentini Caterina Giovanna,Bianchi Maria,Frioni Filippo,Pellegrino Claudio,Sorà Federica,Larocca Luigi Maria,Sica Simona,Bacigalupo Andrea,Teofili Luciana

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference15 articles.

1. Ingram DA, Mead LE, Tanaka H. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004; 104(9):2752-2760.

2. Le Blanc K, Frassoni F, Ball L. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008; 371(9624):1579-1586.

3. Iachininoto MG, Camisa V, Leone L. Effects of exposure to gradient magnetic fields emitted by nuclear magnetic resonance devices on clonogenic potential and proliferation of human hematopoietic stem cells. Bioelectromagnetics. 2016; 37(4):201-211.

4. Chiusolo P, Bregante S, Giammarco S. Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: the role of the conditioning regimen. Am J Hematol. 2021; 96(2):234-240.

5. Wang E, Hutchinson CB, Huang Q. Donor cell-derived leukemias/ myelodyspastic neoplasms in allogeneic hematopoietic stem cell transplant recipients. a clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol. 2011; 135(4):525-540.